IRLAB Publishes Interim Report for the Period January - March 2025

May 7, 2025 1:20 AM

IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company's interim report for the period January-March 2025, has been published.KEY HIGHLIGHTS DURING AND AFTER THE FIRST QUARTERIn mid-January, the company announced that the last patient had completed the full treatment period in the Phase IIb study with pirepemat.In January, the company was...

Read more

Protagonist Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 6, 2025 4:05 PM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today reported financial results for the first quarter ended March 31, 2025, and provided a corporate update."Protagonist is off to a very strong 2025 with multiple transformational events in the first quarter for our two late-stage partnered assets, rusfertide and icotrokinra which are progressing to NDA filings by year end," said Dinesh V. Patel, Ph.D., the Company's...

Read more

Electronic Caregiver Launches First-Ever AI-Powered Virtual Care Ecosystem Featuring Interactive Avatar, Now Available via Athenahealth's EHR Network

May 6, 2025 2:30 PM

Electronic Caregiver, the leader in intelligent virtual care solutions, has announced the direct integration of its revolutionary Addison Care platform into the athenaOne® electronic health record (EHR) system from athenahealth. This marks the first time a fully interoperable, AI-powered 3D virtual caregiver becomes accessible to thousands of healthcare providers nationwide through a leading EHR platform. This integration empowers clinics and...

Read more

CannapharmaRx Continues into New European Market with First Shipment Completed to Germany

May 6, 2025 2:30 PM

CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cannabis cultivation, is pleased to share recent updates, including its latest cultivation activities and sales achievements.Successful Shipments to Israel and GermanyTo date, the Company has successfully completed four shipments to Israel and one to Germany. Customer satisfaction with our proprietary strains remains high, and we are seeing strong demand for continued shipments in...

Read more

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025

May 6, 2025 12:45 PM

Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025. The results will be released after the market close on Thursday, May 15 and the company will host a conference call on Friday, May 16 at 10:00am Eastern Time.Conference Call and...

Read more

Trusti Raises $300K Pre-Seed Round and Launches in Ontario with At-Home Rapid STI Testing Platform

May 6, 2025 12:15 PM

trusti, a women-led healthtech startup, has announced the successful close of a $300,000 pre-seed funding round as it officially launches its at-home rapid STI testing platform in Ontario. The raise marks a major milestone in the company's mission to revolutionize sexual health care through accessible diagnostics and innovative digital education tools.The round includes backing from LOI Venture, co-founded by Ryan Holmes (Founder, Hootsuite) and...

Read more

Avel eCare Honors Nurses and Reinforces Support Through Telemedicine for Nurse Appreciation Week

May 6, 2025 12:00 PM

As the nation celebrates Nurse Appreciation Week, Avel eCare proudly recognizes the extraordinary contributions of nurses across the country and reaffirms its commitment to supporting their work, not only as an employer but as a nationwide telemedicine partner.Nurses are the backbone of the healthcare system. With over 4.3 million registered nurses in the U.S., they represent the largest segment of the healthcare workforce. Yet burnout, staffing...

Read more

‘I’m Here for You:’ How Justin Found the Connections He Needed To Succeed on Dialysis

May 6, 2025 10:15 AM

As a young adult, Justin experienced an issue with his blood that led to hospitalization, the need for higher levels of care-and dialysis. As the DaVita care team started working with Justin and his family, they focused on building trust and creating a connection with him. Eventually, he received a transplant in February 2024.About DaVita Inc.DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to improve quality of...

Read more

Clarity Clinic Expands PHP/IOP Mental Health Services to Arlington Heights, Bringing Specialized Care to the Northwest Suburbs

May 6, 2025 10:00 AM

Clarity Clinic, a leading provider of mental health services in Illinois, is expanding its Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs to its Arlington Heights location to better serve individuals struggling with depression, anxiety, and other mood-related disorders in the northwest suburbs. With the addition of these programs, Clarity Clinic is making structured, evidence-based mental health treatment more accessible...

Read more

Utah Medical Products, Inc. Announces Quarterly Dividend

May 6, 2025 10:00 AM

Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on July 3, 2025 to stockholders of record at the close of business on June 16, 2025. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their...

Read more

Infinx Acquires i3 Verticals' Healthcare Revenue Cycle Management Business

May 6, 2025 10:00 AM

Infinx Healthcare, a leading provider of AI-powered solutions for patient access and revenue cycle management (RCM), today announced it has acquired the Healthcare Revenue Cycle Management Business of i3 Verticals, Inc. (NASDAQ:IIIV).The transaction strengthens Infinx's market presence in the healthcare RCM space and expands its footprint into new customer segments, including academic medical centers and other large provider groups. The...

Read more

Nick Health Launches First Global Digital Cancer Care Platform Offering 24/7 Access to World-Class Oncologists

May 6, 2025 9:00 AM

Nick Health Inc., a new digital health startup dedicated to transforming the cancer care journey, has officially launched its global platform, providing patients and families with unprecedented, on-demand access to expert oncologists, tailored guidance, and holistic support. Founded by Dr. Hossein Sadrzadeh, a Harvard-trained oncologist, and his wife Dr. Zhaleh Alipour, a cancer survivor and psychologist, Nick Health aims to fill critical gaps...

Read more

Glidewell Launches Fusion With BruxZir(TM) Zirconia

May 6, 2025 9:00 AM

Glidewell has launched Fusion with BruxZir™ Zirconia, a modernized bilayered restoration designed to mimic nature perfectly. Priced at just $199 per unit, Fusion with BruxZir Zirconia is for dentists who desire the highest level of esthetics in their smile transformations. To create this new restorative solution, Glidewell uses proprietary manufacturing technology to fuse a milled wraparound zirconia veneer to a milled zirconia core,...

Read more

Fighting the World's Most Devastating Diseases Is the Focus of This Installment of "The Centrifuge Sessions"

May 6, 2025 8:40 AM

At Gilead, we set and achieve bold ambitions in our fight against the world's most devastating diseases. In this installment of The Centrifuge Sessions, See Phan, Vice President, Oncology Clinical Development, discusses Gilead's approach to cancer research and how his team is working to deliver innovative therapies that offer new hope for patients.Gilead Sciences, Inc. Gilead Sciences, Inc. is a research-based biopharmaceutical company that...

Read more

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

May 6, 2025 8:30 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched Lurasidone, a new generic prescription drug in the therapeutic class of antipsychotics.Lurasidone is a generic version of Latuda®. Lurasidone is indicated for the...

Read more

Nerva Completes Mahana Therapeutics Acquisition to Expand Access to Digital Therapies for IBS

May 6, 2025 8:00 AM

Backed by over $80 million in venture funding, Mahana was foundational in establishing prescription digital therapeutics for digestive health. This strategic acquisition strengthens Nerva's leadership in app-based brain-gut therapy and will accelerate its mission to deliver evidence-based, accessible care to the millions of patients living with IBS.IBS is a complex disorder of gut-brain interaction (DGBI), affecting more than 11% of the...

Read more

Global Survey Reveals Urgent Gaps in Awareness, Access, and Treatment for Hepatitis D

May 6, 2025 8:00 AM

A new report released today by the World Hepatitis Alliance (WHA) reveals widespread knowledge gaps, inequities in access, and critical systemic barriers impeding the global fight against hepatitis delta.Also known as hepatitis D, hepatitis delta is a severe liver disease affecting an estimated 12 million people worldwide. It occurs in people living with hepatitis B, leads to faster disease progression, and significantly increases the risk of...

Read more

Why Dr. Shervin Naderi is America's Top Choice for Rhinoplasty

May 6, 2025 8:00 AM

For patients considering rhinoplasty, finding a surgeon with the right combination of technical skill, artistic vision, and experience is essential. Dr. Shervin Naderi of The Naderi Center for Plastic Surgery and Dermatology has been a trusted name in the field for over 20 years, earning recognition from Washingtonian Magazine, Newsweek Magazine, and Castle Connolly and many more recognitions and awards as a "Top Doctor" year after year. With...

Read more

Curiteva & Promimic - Bonded by Innovation

May 6, 2025 8:00 AM

Curiteva, a leader in 3D-printed Trabecular PEEK implant technology, is pleased to announce an expanded partnership with Promimic, pioneers in nanotechnology, delivering advanced implant solutions with unmatched capabilities. The partnership combines Promimic's groundbreaking surface modification with Curiteva's innovative Inspire® technology, establishing a new benchmark in the medical device industry.Through this new global, long-term...

Read more

MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity

May 6, 2025 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on developing breakthrough treatments for neurological and neuropsychiatric conditions, today announced positive results from a neurotoxicity study of Ketamir-2, its novel oral NMDA receptor antagonist. The study was required by the U.S. Food and Drug Administration (FDA) prior to initiating human dosing in the United States.The...

Read more